Thoughts Regarding LDL-P, ApoB, and Remnants – Cholesterol Code
HDL and cardiovascular disease - The Lancet
Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science | ECR Journal
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk | Circulation
Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention | Lipids in Health and Disease | Full Text
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
Measuring cardiovascular disease risk and the importance of apoB - Peter Attia
Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina | Scientific Reports
ApoB and Cardiovascular Risk | Going Lo-Co
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
Metabolites | Free Full-Text | Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
PDF) Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
Odds Ratios for the Risk of Future Coronary Artery Disease, by Quartile... | Download Table
The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk | IntechOpen
Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB /apoA-1 ratio—Experience from the Swedish AMORIS cohort: A cohort study | PLOS Medicine
The relation between ApoB/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome | The Egyptian Heart Journal | Full Text
